ASCP Project ECHO® Videoconference Series on NSCLC
This CME/CMLE-accredited videoconference series provides pathologists and laboratory professionals with knowledge related to best practices in advanced NSCLC diagnosis, testing, and management and guidance on real-life challenges they may face.
Recorded Sessions
Use the buttons below to take the course online for CME/CMLE credit or view the recording on YouTube (no credit).
Videoconference 5: Key Actionable Driver Mutations in Patients with Advanced NSCLC
Originally Broadcast December 2, 2021
Credit: 1 hour CME/CMLE
Need to claim credit for attending the live event? Click here.
Videoconference 4: Advances in Targeted Therapies for Advanced NSCLC
Originally Broadcast October 7, 2021
Credit: 1 hour CME/CMLE
Videoconference 3: Overcoming Challenges to Advanced NSCLC Molecular Testing
Originally Broadcast August 19, 2021
Credit: 1 hour CME/CMLE
Videoconference 2: Best Practices in Advanced NSCLC Specimen Management
Originally Broadcast June 24, 2021
Credit: 1 hour CME/CMLE
Videoconference 1: Optimizing Test Ordering for Patients with Advanced NSCLC
Originally Broadcast April 22, 2021
Credit: 1 hour CME/CMLE
Funded by independent educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Pfizer, Inc.
Learn more about Project ECHO here.
Best Practices in NSCLC Biomarker Testing: An Interactive Videoconference Series for Anatomic Pathology Teams
This highly interactive series is designed to support Anatomic Pathology laboratory managers and their teams, providing them with knowledge related to best practices in NSCLC biomarker testing, examples of success stories, and guidance on real-life challenges they may face.
Previous Sessions
LIS and EHR Implementation and Protocol Optimization for NSCLC Biomarker Testing
May 19, 2022, 2:00-3:00 p.m. EDT
Implementation of the CAP/IASLC/AMP 2018 NSCLC Molecular Testing Guidelines
March 31, 2022, 2:00-3:00 p.m. EDT
Actionable Results and Turnaround Time Indicators for NSCLC Workflows
January 27, 2022, 2:00-3:00 p.m. EST
Standardizing Protocols for Optimal Procurement, Fixation, and Tissue/Cytology Specimen Handling for NSCLC
November 18, 2021, 2:00-3:00 p.m. EST
Would you like to share your challenges and/or best practices?
ASCP is recruiting individuals to share challenges and/or best practices during each upcoming videoconference in this series. If you are interested, we want to hear from you! Please contact grants@ascp.org to learn more.
Developed through commercial sponsorship from Genentech.
The Molecular Biomarker Revolution in Metastatic NSCLC
During this recorded 2022 ASCP Annual Meeting session, multidisciplinary faculty discuss the science and latest evidence on emerging biomarkers, resistance mutations, immuno-oncology (I-O) resistance mechanisms, and I-O treatment options (e.g., combination therapy involving CTLA-4 inhibitors) in metastatic NSCLC. Participants will learn how to integrate next generation sequencing (NGS) into their biomarker testing workflows and optimize its use for patients. Finally, faculty share best practices in biomarker testing, reporting, and communication to help pathologists and laboratory professionals guide medical oncologists and other team members in the appropriate diagnosis, testing, and treatment for patients.
This activity offers 1.0 CME/CMLE credit.
Register for Online Course View on YouTube Download Slide Deck
Funded by an independent educational grant from AstraZeneca Pharmaceuticals.
Advanced Non-Small Cell Lung Cancer Molecular Tumor Board Simulation
This CME/CMLE-accredited 1-hour molecular tumor board simulation is designed to help pathologists, laboratory professionals, and other members of the interdisciplinary cancer care team gain deeper scientific knowledge and skills in diagnosing, testing, and managing advanced non-small cell lung cancer (NSCLC). Throughout the highly interactive molecular tumor board simulation, a multidisciplinary faculty panel will discuss multiple patient cases involving advanced NSCLC, and you will answer questions designed to help you carefully consider the nuances of each case, building your knowledge and skills related to the detection and optimal management of advanced NSCLC.
The activity offers 1.0 CME/CMLE credit.
Register for Online Course Review Case 1 (YouTube) Review Case 2 (YouTube)
Funded by independent educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Pfizer, Inc.
Best Practices in Biomarker Testing for NSCLC Virtual Summit
A free, on-demand summit designed to support AP laboratory managers and their teams in exploring actionable solutions to CQI-related problems
Originally broadcast September 29-30, 2022
This Virtual Summit follows the 4-part Best Practices in NSCLC Biomarker Testing Videoconference Series in which we learned about participants’ specific challenges and areas for opportunity in the lab. In this practical, unique event, we explored actionable CQI solutions to common problems in the workflow through the lens of those who have tackled similar challenges in their lab contexts. Each session closes with a multidisciplinary panel discussion of how the team works through making key decisions related to topics covered.
Session 1: Tissue Acquisition and Processing
Session 2: Ordering and Turnaround Time
Developed through commercial sponsorship from Genentech.
Optimizing Advanced NSCLC Biomarker Testing, Treatment and Management
A free on-demand virtual summit for interprofessional cancer care teams
Originally broadcast May 21, 2021
Up to 4.5 CME/CMLE Credits
Session 1: You’ll learn what factors influence testing selection for patients with advanced NSCLC.
Speakers will discuss what factors influence the selection of particular testing methods, how much tissue is needed for certain types of tests, and the importance of interprofessional collaboration during the testing selection process.
Session 2: You’ll get clarity on biomarker testing methodology and recommendations.
Speakers will discuss the advantages and limitations of using different testing techniques, guidelines, and key discussions between interprofessional team members to optimize biomarker testing and patient care.
Session 3: You’ll gain insight on advanced NSCLC treatment opportunities and optimizing patient care.
Speakers will discuss available guideline-based treatment options, treatment resistance, and potential barriers towards optimizing patient care.
If you were not able to attend the live event, you can use the buttons below to take the course online for CME/CMLE credit or view the recordings on YouTube without credit.
Supported by an independent educational grant from Pfizer, Inc.
NSCLC Podcast
The Molecular Biomarker Revolution in Metastatic NSCLC
During this recorded 2022 ASCP Annual Meeting session, multidisciplinary faculty discuss the science and latest evidence on emerging biomarkers, resistance mutations, immuno-oncology (I-O) resistance mechanisms, and I-O treatment options (e.g., combination therapy involving CTLA-4 inhibitors) in metastatic NSCLC. Participants will learn how to integrate next generation sequencing (NGS) into their biomarker testing workflows and optimize its use for patients. Finally, faculty share best practices in biomarker testing, reporting, and communication to help pathologists and laboratory professionals guide medical oncologists and other team members in the appropriate diagnosis, testing, and treatment for patients.
Faculty:
Diana N. Ionescu MD, FRCPC, FCAP
Consultant Pathologist and Medical Lead Anatomical Pathology
Medical Director BC Cervical Cancer Screening Laboratory
Medical Director Clinical Trials, BC Cancer Laboratories
Clinical Professor of Pathology, University of British Columbia
Doru Paul, MD, PhD
Attending Physician, Division of Hematology and Medical Oncology
Weill Cornell and New York Presbyterian Hospital
Access Podcast
Funded by an independent educational grant from AstraZeneca Pharmaceuticals.
Access all of ASCP’s Inside the Lab podcasts here.